Enhancing the benefits from biomedical and health research spillovers between public, private and charitable sectors in the UK
Expert InsightsPublished Oct 1, 2010
Expert InsightsPublished Oct 1, 2010
In innovation processes, it is well established that knowledge spillovers can exist, whereby investments in knowledge creation by one party produces external benefits for other parties. This document highlights key points from a high-level Forum organised and facilitated by the Office of Health Economics and RAND Europe which met in Cambridge on 11th May 2010 to discuss the nature of spillover effects from biomedical and health research and strategies to realise their benefits. The Forum discussed a number of aspects of spillovers and identified the top priorities for policy research that could help bring spillover effects more explicitly into policy decisions.
The research described in this report was conducted by RAND Europe.
This publication is part of the RAND occasional paper series. RAND occasional papers were products of RAND from 2003 to 2013 that included informed perspectives on a timely policy issue, discussions of new research methodologies, essays, papers presented at a conference, and summaries of work in progress.
This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.
RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.